<SEC-DOCUMENT>0000921895-25-000843-index.html : 20250321 <SEC-HEADER>0000921895-25-000843.hdr.sgml : 20250321 <ACCEPTANCE-DATETIME>20250321115825 ACCESSION NUMBER: 0000921895-25-000843 CONFORMED SUBMISSION TYPE: SCHEDULE 13D/A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20250321 DATE AS OF CHANGE: 20250321 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001593899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460574869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-91836 FILM NUMBER: 25759653 BUSINESS ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: SUITE 2100 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-204-8109 MAIL ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: SUITE 2100 CITY: BOSTON STATE: MA ZIP: 02110 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Radoff Bradley Louis CENTRAL INDEX KEY: 0001380585 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SCHEDULE 13D/A MAIL ADDRESS: STREET 1: 2727 KIRBY DRIVE STREET 2: UNIT 29L CITY: HOUSTON STATE: TX ZIP: 77098 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13D/A <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-2 <SEQUENCE>2 <FILENAME>ex2to13da109076068_032125.htm <DESCRIPTION>TRANSACTIONS IN SECURITIES <TEXT> Document 2 - file: ex2to13da109076068_032125.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>3 <FILENAME>ex991to13da109076068_032125.htm <DESCRIPTION>GROUP AGREEMENT, DATED MARCH 20, 2025 <TEXT> Document 3 - file: ex991to13da109076068_032125.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>4 <FILENAME>ex992to13da109076068_032125.htm <DESCRIPTION>POWERS OF ATTORNEY <TEXT> Document 4 - file: ex992to13da109076068_032125.htm
</DOCUMENT> </SEC-DOCUMENT>